de Jonge E - Search Results

1

Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.

de Jonge E, Dekkers PE, Creasey AA, Hack CE, Paulson SK, Karim A, Kesecioglu J, Levi M, van Deventer SJ, van Der Poll T. de Jonge E, et al. Blood. 2000 Feb 15;95(4):1124-9. Blood. 2000. PMID: 10666180 Free article. Clinical Trial.

2

The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation.

Franco RF, de Jonge E, Dekkers PE, Timmerman JJ, Spek CA, van Deventer SJ, van Deursen P, van Kerkhoff L, van Gemen B, ten Cate H, van der Poll T, Reitsma PH. Franco RF, et al. Among authors: de jonge e. Blood. 2000 Jul 15;96(2):554-9. Blood. 2000. PMID: 10887118 Free article.

3

Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines.

Juffermans NP, Paxton WA, Dekkers PE, Verbon A, de Jonge E, Speelman P, van Deventer SJ, van der Poll T. Juffermans NP, et al. Among authors: de jonge e. Blood. 2000 Oct 15;96(8):2649-54. Blood. 2000. PMID: 11023494 Free article.

4

Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia.

de Jonge E, Dekkers PE, Creasey AA, Hack CE, Paulson SK, Karim A, Kesecioglu J, Levi M, van Deventer SJ, van der Poll T. de Jonge E, et al. J Infect Dis. 2001 Jun 15;183(12):1815-8. doi: 10.1086/320723. Epub 2001 May 11. J Infect Dis. 2001. PMID: 11372037 Clinical Trial.

5

Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.

de Jonge E, van der Poll T, Kesecioglu J, Levi M. de Jonge E, et al. Semin Thromb Hemost. 2001 Dec;27(6):667-74. doi: 10.1055/s-2001-18871. Semin Thromb Hemost. 2001. PMID: 11740690 Review.

6

Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin-10 response in human endotoxemia.

de Pont AC, Moons AH, de Jonge E, Meijers JC, Vlasuk GP, Rote WE, Büller HR, van der Poll T, Levi M. de Pont AC, et al. Among authors: de jonge e. J Thromb Haemost. 2004 Jan;2(1):65-70. doi: 10.1111/j.1538-7836.2004.00526.x. J Thromb Haemost. 2004. PMID: 14717968 Free article. Clinical Trial.

7

Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects.

de Jonge E, Levi M, Berends F, van der Ende AE, ten Cate JW, Stoutenbeek CP. de Jonge E, et al. Thromb Haemost. 1998 Feb;79(2):286-90. Thromb Haemost. 1998. PMID: 9493577 Clinical Trial.

8

Current drug treatment strategies for disseminated intravascular coagulation.

de Jonge E, Levi M, Stoutenbeek CP, van Deventer SJ. de Jonge E, et al. Drugs. 1998 Jun;55(6):767-77. doi: 10.2165/00003495-199855060-00004. Drugs. 1998. PMID: 9617592 Review.

9

Disseminated intravascular coagulation.

Levi M, de Jonge E, van der Poll T, ten Cate H. Levi M, et al. Among authors: de jonge e. Thromb Haemost. 1999 Aug;82(2):695-705. Thromb Haemost. 1999. PMID: 10605770 Review. No abstract available.

10

Sequential measurements of chemokines in urosepsis and experimental endotoxemia.

Olszyna DP, Prins JM, Dekkers PE, De Jonge E, Speelman P, Van Deventer SJ, Van Der Poll T. Olszyna DP, et al. Among authors: de jonge e. J Clin Immunol. 1999 Nov;19(6):399-405. doi: 10.1023/a:1020554817047. J Clin Immunol. 1999. PMID: 10634213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters